RIMIFON 500 mg/5 ml, solution for injection/for infusion 6 ampoules of 5 ml
Active ingredients: Isoniazid
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection or infusion6 ampoules of 5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIMIFON 500 mg/5 ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 6 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- PHARMHOLDING (LUXEMBOURG)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 May 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69515643CIP73477984CIP133400934779848Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ISONIAZIDEsolution | 500,0 mg · une ampoule de 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.